Open Philanthropy recommended three grants totaling $2,320,803 over two years to the Malaria Research and Training Center to support a proof-of-concept clinical trial led by Alassane Dicko. The trial will take place in Mali and assess the safety and efficacy of the leading malaria transmission-blocking monoclonal antibody (TB31F) against natural infections.
This falls within Open Philanthropy’s focus area of global health R&D.